Laser Captur e Microdissectio n

Size: px
Start display at page:

Download "Laser Captur e Microdissectio n"

Transcription

1 Laser Captur e Microdissectio n Methods and Protocols Graeme I. Murray Stephanie Curran

2

3 Preface Contributors v x i PART I. INTRODUCTIO N 1. An Introduction to Laser-Based Tissue Microdissection Technique s Stephanie Curran and Graeme I. Murray 3 PART II. MICRODISSECTION AND DNA ANALYSI S 2. Methacarn Fixation for Genomic DNA Analysi s in Microdissected Cell s Makoto Shibutani and Chikako Uneyama Multiplex Quantitative Real-Time PC R of Laser Microdissected Tissu e Patrick H. Rooney Comparative Genomic Hybridization Using DN A From Laser Capture Microdissected Tissu e Grace Callagy, Lucy Jackson, and Carlos Caldas Detection of Ki-ras and 1353 Mutation s by Laser Capture Microdissection/PCR/SSC P Deborah Dillon, Karl Zheng, Brina Negin, and Jose Costa Whole-Genome Allelotyping Using Laser Microdissected Tissu e Colleen M. Feltmate and Samuel C. Mok Microdissection for Detecting Genetic Aberration s in Early and Advanced Human Urinary Bladder Cance r Arndt Hartmann, Robert Stoehr, Peter J. Wild, Wolfgang Dietmaier, and Ruth Knuechel Laser Microdissection for Microsatellite Analysi s in Colon and Breast Cance r Peter J. Wild, Robert Stoehr, Ruth Knuechel, Arndt Hartmann, and Wolfgang Dietmaier Assessment of RET/PTC Oncogene Activation in Thyroid Nodule s Utilizing Laser Microdissection Followed by Nested RT-PC R Giovanni Tallini and Guilherme Brandao Combined Laser-Assisted Microdissection and Shor t Tandem Repeat Analysis for Detection of In Sit u Microchimerism After Solid Organ Transplantatio n Ulrich Lehmann, Anne Versmold, and Hans Kreipe 113

4 PART III. RNA AND GENE EXPRESSION STUDIE S USING MICRODISSECTED CELL S 11. Laser-Assisted Microdissection of Membrane-Mounte d Tissue Section s Lise Mette Gjerdrum and Stephen Hamilton-Dutoit Laser-Assisted Microdissection of Membrane-Mounted Section s Following Immunohistochemistry and In Situ Hybridizatio n Lise Mette Gjerdrum and Stephen Hamilton-Dutoit Laser-Assisted Cell Microdissection Using the PALM Syste m Patrick Micke, Arne Östman, Joakim Lundeberg, and Fredrik Ponten Laser Microdissection and RNA Analysi s Ludger Fink and Rainer Maria Bohle Gene Expression Profiling of Primary Tumor Cell Population s Using Laser Capture Microdissection, RNA Transcrip t Amplification, and GeneChip Microarray s Veronica I. Luzzi, Victoria Holtschlag, and Mark A. Watson Quantification of Gene Expression in Mous e and Human Renal Proximal Tubule s Jun-ya Kaimori, Masaru Takenaka, and Kousaku Okubo Laser Capture Microdissection for Analysis of Macrophag e Gene Expression From Atherosclerotic Lesion s Eugene Trogan and Edward A. Fisher Analysis of Pituitary Cells by Laser Capture Microdissectio n Ricardo V. Lloyd, Xiang Qian, Long fin, Katharina Ruebel, Jill Bayliss, Shuya Zhang, and Ikuo Kobayaski 23 3 PART IV. MICRODISSECTION TECHNIQUE S AND APPLICATIONS IN PROTEOMIC S 19. Laser Capture Microdissection and Colorectal Cancer Proteomic s Laura C. Lawrie and Stephanie Curran Proteomic Analysis of Human Bladder Tissu e Using SELD I Approach Following Microdissection Technique s Rene C. Krieg, Nadine T. Gaisa, Cloud P. Paweletz, and Ruth Knuechel 25 5 PART V. MICRODISSECTION AND MOLECULAR ANALYSI S OF MICROORGANISM S 21. Genetic Analysis of HIV by In Situ PCR-Directe d Laser Capture Microscopy of Infected Cell s Daniele Marras 271

5 22. Use of Laser Capture Microdissection Togethe r With In Situ Hybridization and Real-Time PC R to Study the Distribution of Latent Herpes Simple x Virus Genomes in Mouse Trigeminal Ganglio n Xiao-Ping Chen, Marina Mata, and David J. Fink Laser Capture Microdissection and PC R for Analysis of Human Papilloma Virus Infectio n Kheng Chew, Patrick H. Rooney, Margaret E. Cruickshank, and Graeme I. Murray Laser Capture Microdissection of Hepatic Stages of the Huma n Parasite Plasmodium falciparum for Molecular Analysi s Jean-Philippe Semblat, Olivier Silvie, Jean-Francois Franetich, and Dominique Mazier 30 1 Index 309

Human Retroviru s Protocol s

Human Retroviru s Protocol s Human Retroviru s Protocol s Virology and Molecular Biolog y Tuofu Zhu Methods in Molecular Biology' Preface Contributors v x i PART I. METHODS FOR VIRUS ISOLATION AND DETECTIO N 1 Enhanced Culture Assay

More information

School of Pathology and Laboratory Medicine: Current and New Research Interests

School of Pathology and Laboratory Medicine: Current and New Research Interests School of Pathology and Laboratory Medicine: Current and New Research Interests W/Professor Wendy Erber Current Research Interests Viral immunology and immunogenetics Bone pathology and cell signalling

More information

Profiles of gene expression & diagnosis/prognosis of cancer. MCs in Advanced Genetics Ainoa Planas Riverola

Profiles of gene expression & diagnosis/prognosis of cancer. MCs in Advanced Genetics Ainoa Planas Riverola Profiles of gene expression & diagnosis/prognosis of cancer MCs in Advanced Genetics Ainoa Planas Riverola Gene expression profiles Gene expression profiling Used in molecular biology, it measures the

More information

Activation of cellular proto-oncogenes to oncogenes. How was active Ras identified?

Activation of cellular proto-oncogenes to oncogenes. How was active Ras identified? Dominant Acting Oncogenes Eugene E. Marcantonio, M.D. Ph.D. Oncogenes are altered forms of normal cellular genes called proto-oncogenes that are involved in pathways regulating cell growth, differentiation,

More information

Liquid Biopsy. Jesus Garcia-Foncillas MD PhD. Director

Liquid Biopsy. Jesus Garcia-Foncillas MD PhD. Director Liquid Biopsy Jesus Garcia-Foncillas MD PhD Director Main issues about liquid biopsies New paradigm: Precision Medicine Heterogeneity & Dynamics Surrogate mirror for the tumor CTCs in colon cancer ctdna:

More information

Supplementary Information Titles Journal: Nature Medicine

Supplementary Information Titles Journal: Nature Medicine Supplementary Information Titles Journal: Nature Medicine Article Title: Corresponding Author: Supplementary Item & Number Supplementary Fig.1 Fig.2 Fig.3 Fig.4 Fig.5 Fig.6 Fig.7 Fig.8 Fig.9 Fig. Fig.11

More information

الحترمونا من خري الدعاء

الحترمونا من خري الدعاء الحترمونا من خري الدعاء Instructions for candidates The examination consists of 30 multiple choice questions, each divided into 5 different parts. Each part contains a statement which could be true or

More information

Anatomic Molecular Pathology: An Emerging Field

Anatomic Molecular Pathology: An Emerging Field Anatomic Molecular Pathology: An Emerging Field Antonia R. Sepulveda M.D., Ph.D. University of Pennsylvania asepu@mail.med.upenn.edu 2008 ASIP Annual Meeting Anatomic pathology (U.S.) is a medical specialty

More information

REGULATIONS FOR THE POSTGRADUATE DIPLOMA IN MOLECULAR AND DIAGNOSTIC PATHOLOGY (PDipMDPath)

REGULATIONS FOR THE POSTGRADUATE DIPLOMA IN MOLECULAR AND DIAGNOSTIC PATHOLOGY (PDipMDPath) REGULATIONS FOR THE POSTGRADUATE DIPLOMA IN MOLECULAR AND DIAGNOSTIC PATHOLOGY (PDipMDPath) (See also General Regulations and Regulations for Taught Postgraduate Curricula) M.129 Admission requirements

More information

Innovations in nucleic acid amplification technologies. Automated platforms for NAT. Microfluidics Digital PCR Innovations in nucleic acid microarrays

Innovations in nucleic acid amplification technologies. Automated platforms for NAT. Microfluidics Digital PCR Innovations in nucleic acid microarrays About the author Disclaimer EXECUTIVE SUMMARY Molecular diagnostic technologies Healthcare-associated infections Sexually transmitted HPVs HIV and hepatitis viruses Market outlook and forecasts Molecular

More information

Measure Description. Denominator Statement

Measure Description. Denominator Statement CMS ID/CMS QCDR ID: CAP 18 Title: Mismatch Repair (MMR) or Microsatellite Instability (MSI) Biomarker Testing to Inform Clinical Management and Treatment Decisions in Patients with Primary or Metastatic

More information

Cytogenetics Technologies, Companies & Markets

Cytogenetics Technologies, Companies & Markets Cytogenetics Technologies, Companies & Markets By Prof. K. K. Jain MD, FRACS, FFPM Jain PharmaBiotech Basel, Switzerland November 2018 A Jain PharmaBiotech Report A U T H O R ' S B I O G R A P H Y Professor

More information

Ch 18 Infectious Diseases Affecting Cardiovascular and Lymphatic Systems

Ch 18 Infectious Diseases Affecting Cardiovascular and Lymphatic Systems Ch 18 Infectious Diseases Affecting Cardiovascular and Lymphatic Systems Highlight Disease: Malaria World s dominant protozoal disease. Four species of Plasmodium: P. falciparum (malignant), P. vivax (begnin),

More information

Guangdong Medical University, Zhanjiang, China; 5 Guangxi Medical University, Nanning, China; 6 Department of Pathology, University of Michigan

Guangdong Medical University, Zhanjiang, China; 5 Guangxi Medical University, Nanning, China; 6 Department of Pathology, University of Michigan Overexpression of FAM83H-AS1 indicates poor patient survival and knockdown impairs cell proliferation and invasion via MET/EGFR signaling in lung cancer Jie Zhang 1,2, Shumei Feng 3, Wenmei Su 4, Shengbin

More information

3 rd course on BREAST CANCER: FROM CLINICS TO BIOLOGY June 19-23, 2017 Institut Curie - Training Unit - International Course

3 rd course on BREAST CANCER: FROM CLINICS TO BIOLOGY June 19-23, 2017 Institut Curie - Training Unit - International Course 08/03/2017 Monday, june 19 th : Clinical management Chair: Roman Rouzier 10:15 Training Unit Welcome: practical aspects & coffee 10:30 11:15 11:15 11:45 Anne Vincent-Salomon & Roman Rouzier Mathilde His

More information

Doctor of Philosophy

Doctor of Philosophy Regulation of Gene Expression of the 25-Hydroxyvitamin D la-hydroxylase (CYP27BI) Promoter: Study of A Transgenic Mouse Model Ivanka Hendrix School of Molecular and Biomedical Science The University of

More information

Assessment of Breast Cancer with Borderline HER2 Status Using MIP Microarray

Assessment of Breast Cancer with Borderline HER2 Status Using MIP Microarray Assessment of Breast Cancer with Borderline HER2 Status Using MIP Microarray Hui Chen, Aysegul A Sahin, Xinyan Lu, Lei Huo, Rajesh R Singh, Ronald Abraham, Shumaila Virani, Bal Mukund Mishra, Russell Broaddus,

More information

MicroRNA expression profiling and functional analysis in prostate cancer. Marco Folini s.c. Ricerca Traslazionale DOSL

MicroRNA expression profiling and functional analysis in prostate cancer. Marco Folini s.c. Ricerca Traslazionale DOSL MicroRNA expression profiling and functional analysis in prostate cancer Marco Folini s.c. Ricerca Traslazionale DOSL What are micrornas? For almost three decades, the alteration of protein-coding genes

More information

Characterisation of structural variation in breast. cancer genomes using paired-end sequencing on. the Illumina Genome Analyser

Characterisation of structural variation in breast. cancer genomes using paired-end sequencing on. the Illumina Genome Analyser Characterisation of structural variation in breast cancer genomes using paired-end sequencing on the Illumina Genome Analyser Phil Stephens Cancer Genome Project Why is it important to study cancer? Why

More information

MT09 - Normal Human Tissue Microarray, FDA

MT09 - Normal Human Tissue Microarray, FDA Reveal Biosciences offers Histochemical Staining, Immunohistochemistry (IHC), In Situ Hybridization (ISH), Whole Slide Imaging, and Quantitative Image Analysis on any TMA MT09 - Normal Human Tissue Microarray,

More information

Molecular and genetic analysis of stromal fibroblasts in prostate cancer

Molecular and genetic analysis of stromal fibroblasts in prostate cancer Final report ESMO Translational Research Fellowship 2010-2011 Molecular and genetic analysis of stromal fibroblasts in prostate cancer Michalis Karamouzis Host Institute Department of Biological Chemistry,

More information

Evolution of Pathology

Evolution of Pathology 1 Traditional pathology Molecular pathology 2 Evolution of Pathology Gross Pathology Cellular Pathology Morphologic Pathology Molecular/Predictive Pathology Antonio Benivieni (1443-1502): First autopsy

More information

Clinical HIV-2 Viral Load Testing of a Large Population of HIV-2 Infected Individuals

Clinical HIV-2 Viral Load Testing of a Large Population of HIV-2 Infected Individuals Clinical HIV-2 Viral Load Testing of a Large Population of HIV-2 Infected Individuals Linda M. Styer Wadsworth Center, NYSDOH ** The authors have no conflicts of interest to disclose ** HIV-2 viral load

More information

HIV recombination in the development of drug resistance

HIV recombination in the development of drug resistance HIV recombination in the development of drug resistance A. Schultz T. Tänzer Department of Virology J. Reiter University of the Saarland T. Breinig A. Meyerhans J-P. Vartanian Unité de Rétrovirologie Moléculaire

More information

IKMG Research Group - 4 th International Meeting PROGRAM

IKMG Research Group - 4 th International Meeting PROGRAM IKMG Research Group - 4 th International Meeting PROGRAM SCIENTIFIC & ORGANIZING COMMITTEE ROYAL Virginie, MD - Chair of the 4th IKMG Meeting VENNER Christopher, MD Co-chair of the 4th IKMG Meeting BRIDOUX

More information

American Society of Cytopathology Core Curriculum in Molecular Biology

American Society of Cytopathology Core Curriculum in Molecular Biology American Society of Cytopathology Core Curriculum in Molecular Biology American Society of Cytopathology Core Curriculum in Molecular Biology Chapter 1 Molecular Basis of Cancer Molecular Oncology Keisha

More information

MEDICAL POLICY. SUBJECT: MOLECULAR PANEL TESTING OF CANCERS TO IDENTIFY TARGETED THERAPIES (Excluding NSCLC and CRC) EFFECTIVE DATE: 12/21/17

MEDICAL POLICY. SUBJECT: MOLECULAR PANEL TESTING OF CANCERS TO IDENTIFY TARGETED THERAPIES (Excluding NSCLC and CRC) EFFECTIVE DATE: 12/21/17 MEDICAL POLICY SUBJECT: MOLECULAR PANEL TESTING OF PAGE: 1 OF: 5 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product, including

More information

THYROID TUMOR DIAGNOSIS: MARKER OF THE MONTH CLUB

THYROID TUMOR DIAGNOSIS: MARKER OF THE MONTH CLUB THYROID TUMOR DIAGNOSIS: MARKER OF THE MONTH CLUB CHARACTERISTIC OF THE IDEAL TUMOR MARKER Specific Sensitive Easy to perform Easy to interpret Adaptable to FNA Reasonable cost (CHEAP) THYROID TUMOR MARKERS

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION Supplementary Figure 1. Histogram showing hybridization signals for chicken (left) and quail (right) genomic DNA analyzed by Chicken GeneChip (n=3). www.nature.com/nature 1 Supplementary Figure 2. Independent

More information

Converting the Hype into Reality: Realizing the Potential of Cell-Free DNA

Converting the Hype into Reality: Realizing the Potential of Cell-Free DNA Converting the Hype into Reality: Realizing the Potential of Cell-Free DNA Lucy Xu, Ph.D. Associate Director Clinical Biomarker Research Eisai Inc. Woodcliff Lake, NJ Precision LBx Summit San Diego, CA

More information

2016 SUMMER RESEARCH CONFERENCE AUA/SBUR 2016 SUMMER RESEARCH CONFERENCE. Targeting Epigenetics and Genome Regulation to Improve Urologic Health

2016 SUMMER RESEARCH CONFERENCE AUA/SBUR 2016 SUMMER RESEARCH CONFERENCE. Targeting Epigenetics and Genome Regulation to Improve Urologic Health 2016 SUMMER RESEARCH CONFERENCE AUA/SBUR 2016 SUMMER RESEARCH CONFERENCE Targeting Epigenetics and Genome Regulation to Improve Urologic Health AUA Headquarters Linthicum, MD JULY 16-17, 2016 Understanding

More information

Tumor Immunity and Immunotherapy. Andrew Lichtman M.D., Ph.D. Brigham and Women s Hospital Harvard Medical School

Tumor Immunity and Immunotherapy. Andrew Lichtman M.D., Ph.D. Brigham and Women s Hospital Harvard Medical School Tumor Immunity and Immunotherapy Andrew Lichtman M.D., Ph.D. Brigham and Women s Hospital Harvard Medical School Lecture Outline Evidence for tumor immunity Types of tumor antigens Generation of anti-tumor

More information

Non-Profit Startup Paradigm Launches Cancer Panel Based on DNA, RNA Sequencing

Non-Profit Startup Paradigm Launches Cancer Panel Based on DNA, RNA Sequencing Non-Profit Startup Paradigm Launches Cancer Panel Based on DNA, RNA Sequencing April 11, 2014 By Tony Fong Non-profit diagnostics outfit Paradigm last month joined a growing list of entrants in the clinical

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION DOI: 10.1038/ncb2607 Figure S1 Elf5 loss promotes EMT in mammary epithelium while Elf5 overexpression inhibits TGFβ induced EMT. (a, c) Different confocal slices through the Z stack image. (b, d) 3D rendering

More information

Human intestinal microbiology and probiotics

Human intestinal microbiology and probiotics Human intestinal microbiology and probiotics Michiel Kleerebezem Wageningen Centre for Food Sciences Wageningen University NIZO food research P.O. Box 20 6710 BA Ede The Netherlands phone: +31-(0)318-659629

More information

Influenza virus exploits tunneling nanotubes for cell-to-cell spread

Influenza virus exploits tunneling nanotubes for cell-to-cell spread Supplementary Information Influenza virus exploits tunneling nanotubes for cell-to-cell spread Amrita Kumar 1, Jin Hyang Kim 1, Priya Ranjan 1, Maureen G. Metcalfe 2, Weiping Cao 1, Margarita Mishina 1,

More information

Youngnam Cho. National Cancer Center Biomarker Branch

Youngnam Cho. National Cancer Center Biomarker Branch Youngnam Cho National Cancer Center Biomarker Branch Contents 1. Liquid Biopsy 2. Circulating Tumor Cells from Blood 3. Cell-free DNA from Blood 1. Liquid biopsy Cancer Diagnosis IMAGING TISSUE BIOPSY

More information

Epigenetic inactivation of the CpG demethylase TET1 as a DNA

Epigenetic inactivation of the CpG demethylase TET1 as a DNA Epigenetic inactivation of the CpG demethylase TET1 as a DNA methylation feedback loop in human cancers Lili Li 1, Chen Li 1, Haitao Mao 1, Zhenfang Du 1, Wai Yee Chan 2, Paul Murray 3, Bing Luo 4, Anthony

More information

DETERMINATION OF K-RAS MUTATION IN COLORECTAL AND LUNG CANCER

DETERMINATION OF K-RAS MUTATION IN COLORECTAL AND LUNG CANCER 665 J App Pharm 03(04): 655-669; October, 2012 Andreas et al., 2012 Short Communication DETERMINATION OF K-RAS MUTATION IN COLORECTAL AND LUNG CANCER E.Andreas 1,2,3, Ali Mujahid 1,3, Attia Youssef 1,

More information

M ETHODS IN MOLECULAR BIOLOGY

M ETHODS IN MOLECULAR BIOLOGY M ETHODS IN MOLECULAR BIOLOGY Series Editor John M. Walker School of Life Sciences University of Hertfordshire Hatfield, Hertfordshire, AL10 9AB, UK For other titles published in this series, go to www.springer.com/series/7651

More information

(A) PCR primers (arrows) designed to distinguish wild type (P1+P2), targeted (P1+P2) and excised (P1+P3)14-

(A) PCR primers (arrows) designed to distinguish wild type (P1+P2), targeted (P1+P2) and excised (P1+P3)14- 1 Supplemental Figure Legends Figure S1. Mammary tumors of ErbB2 KI mice with 14-3-3σ ablation have elevated ErbB2 transcript levels and cell proliferation (A) PCR primers (arrows) designed to distinguish

More information

SARS and the Clinical Laboratory

SARS and the Clinical Laboratory SARS and the Clinical Laboratory Susan M. Poutanen, MD, MPH, FRCPC Microbiologist, Toronto Medical Labs & Mount Sinai Hosp. Infect. Dis. Clinician, University Health Network & Mount Sinai Hosp. Assistant

More information

KYOUNGMI KIM, Ph. D. Curriculum Vitae

KYOUNGMI KIM, Ph. D. Curriculum Vitae Kyoungmi Kim 1 KYOUNGMI KIM, Ph. D. Curriculum Vitae Section on Statistical Genetics School of Public Health Ryals Public Health Building Suite 327 1665 University Boulevard -0022 Phone: 205. 996.4067

More information

Chromothripsis: A New Mechanism For Tumorigenesis? i Fellow s Conference Cheryl Carlson 6/10/2011

Chromothripsis: A New Mechanism For Tumorigenesis? i Fellow s Conference Cheryl Carlson 6/10/2011 Chromothripsis: A New Mechanism For Tumorigenesis? i Fellow s Conference Cheryl Carlson 6/10/2011 Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development Cell 144,

More information

VIRUSES. 1. Describe the structure of a virus by completing the following chart.

VIRUSES. 1. Describe the structure of a virus by completing the following chart. AP BIOLOGY MOLECULAR GENETICS ACTIVITY #3 NAME DATE HOUR VIRUSES 1. Describe the structure of a virus by completing the following chart. Viral Part Description of Part 2. Some viruses have an envelope

More information

No evidence of clonally selected somatic genomic alterations in cancer associated

No evidence of clonally selected somatic genomic alterations in cancer associated Supplementary Data Resource No evidence of clonally selected somatic genomic alterations in cancer associated fibroblasts from human breast and ovarian carcinomas Wen Qiu, Min Hu, Anita Sridhar, Ken Opeskin,

More information

CANCER. Inherited Cancer Syndromes. Affects 25% of US population. Kills 19% of US population (2nd largest killer after heart disease)

CANCER. Inherited Cancer Syndromes. Affects 25% of US population. Kills 19% of US population (2nd largest killer after heart disease) CANCER Affects 25% of US population Kills 19% of US population (2nd largest killer after heart disease) NOT one disease but 200-300 different defects Etiologic Factors In Cancer: Relative contributions

More information

What causes cancer? Physical factors (radiation, ionization) Chemical factors (carcinogens) Biological factors (virus, bacteria, parasite)

What causes cancer? Physical factors (radiation, ionization) Chemical factors (carcinogens) Biological factors (virus, bacteria, parasite) Oncogenes What causes cancer? Chemical factors (carcinogens) Physical factors (radiation, ionization) Biological factors (virus, bacteria, parasite) DNA Mutation or damage Oncogenes Tumor suppressor genes

More information

Drugs, Driving DQG 7UDI½F 6DIHW\ (GLWHG E\ - & 9HUVWHU 6 5 3DQGL 3HUXPDO - * 5DPDHNHUV DQG - - GH *LHU %LUNKlXVHU %DVHO À %RVWRQ À %HUOLQ

Drugs, Driving DQG 7UDI½F 6DIHW\ (GLWHG E\ - & 9HUVWHU 6 5 3DQGL 3HUXPDO - * 5DPDHNHUV DQG - - GH *LHU %LUNKlXVHU %DVHO À %RVWRQ À %HUOLQ Drugs, Driving Contents Contents V Dedication... IX Credits and acknowledgements... XI List of contributors... XIII Preface... XIX... 1 Henry J. Moller Worldwide trends in alcohol and drug impaired driving...

More information

Identification of Predictive Biomarker in Metastatic Colorectal Cancer: ProfiLer Experience

Identification of Predictive Biomarker in Metastatic Colorectal Cancer: ProfiLer Experience Identification of Predictive Biomarker in Metastatic Colorectal Cancer: ProfiLer Experience XIAOJUN JIANG MENTORS: OLIVIER TREDAN & JEAN-YVES BLAY www.cancer-lyric.com Collect 2000 tumors of all kinds

More information

Viruses. Rotavirus (causes stomach flu) HIV virus

Viruses. Rotavirus (causes stomach flu) HIV virus Viruses Rotavirus (causes stomach flu) HIV virus What is a virus? A virus is a microscopic, infectious agent that may infect any type of living cell. Viruses must infect living cells in order to make more

More information

Primary enteric adenocarcinoma with predominantly signet ring features of the lung: A case report with clinicopathological and molecular findings

Primary enteric adenocarcinoma with predominantly signet ring features of the lung: A case report with clinicopathological and molecular findings CASE REPORT Primary enteric adenocarcinoma with predominantly signet ring features of the lung: A case report with clinicopathological and molecular findings Makoto Nagashima 1, Ayako Moriyama 1, Yasuo

More information

Nutrigenomics. Sejal Parekh Biochem 118Q December 2, 2010 Doug Brutlag

Nutrigenomics. Sejal Parekh Biochem 118Q December 2, 2010 Doug Brutlag Nutrigenomics Sejal Parekh Biochem 118Q December 2, 2010 Doug Brutlag Roadmap What is it? What prompted it? Goals Tools Methods Example Problems Cartoons! What is it? Using genomics tools to research effects

More information

Enterprise Interest Thermo Fisher Scientific / Employee

Enterprise Interest Thermo Fisher Scientific / Employee Enterprise Interest Thermo Fisher Scientific / Employee A next-generation sequencing assay to estimate tumor mutation load from FFPE research samples Fiona Hyland. Director of R&D, Bioinformatics Clinical

More information

Applications. in Oncology

Applications. in Oncology Kewal K. Jain Applications of Biotechnology in Oncology Applications of Biotechnology in Oncology Applications of Biotechnology in Oncology Kewal K. Jain, MD, FRACS, FFPM Jain PharmaBiotech, Basel, Switzerland

More information

Cancer genetics

Cancer genetics Cancer genetics General information about tumorogenesis. Cancer induced by viruses. The role of somatic mutations in cancer production. Oncogenes and Tumor Suppressor Genes (TSG). Hereditary cancer. 1

More information

Trial Objectives immunogenicity safety

Trial Objectives immunogenicity safety Optimal priming of poxvirus vector (NYVAC)-based HIV vaccine regimens requires 3 DNA injections. Long term Results of the EV03/ANRS Vac20 Phase I/II Trial. Yves Levy, Kim Ellefsen, Wolfgang Stöehr, Pierre-Alexandre

More information

Session 4 Rebecca Poulos

Session 4 Rebecca Poulos The Cancer Genome Atlas (TCGA) & International Cancer Genome Consortium (ICGC) Session 4 Rebecca Poulos Prince of Wales Clinical School Introductory bioinformatics for human genomics workshop, UNSW 20

More information

Application. Application of molecular biology methods in hematology and oncology. Oncogenes are involved in:

Application. Application of molecular biology methods in hematology and oncology. Oncogenes are involved in: Application Application of molecular biology methods in hematology and oncology Research on the etiology of cancer Diagnostics / Differential diagnostics Stratifying for treatment Prognosing the outcome

More information

Is aspirin ready for colorectal cancer chemoprevention and adjuvant therapy?

Is aspirin ready for colorectal cancer chemoprevention and adjuvant therapy? Is aspirin ready for colorectal cancer chemoprevention and adjuvant therapy? Robert Benamouzig Service de Gastroentérologie Hôpital Avicenne Bobigny, France Aspirin and Colorectal carcinogenesis Aspirin

More information

8/1/2016. FDG uptake in a heterogeneous microenvironment: A single-cell study. Heterogeneity of FDG uptake in tumors grafts. Goals of the study

8/1/2016. FDG uptake in a heterogeneous microenvironment: A single-cell study. Heterogeneity of FDG uptake in tumors grafts. Goals of the study FDG uptake in a heterogeneous microenvironment: A single-cell study J O IN T AAPM- W M I S S YMP O S IU M: M E TA B O L IC I MA G IN G OF C A N C E R Guillem Pratx, PhD Radiation Oncology & Medical Physics

More information

NGS in tissue and liquid biopsy

NGS in tissue and liquid biopsy NGS in tissue and liquid biopsy Ana Vivancos, PhD Referencias So, why NGS in the clinics? 2000 Sanger Sequencing (1977-) 2016 NGS (2006-) ABIPrism (Applied Biosystems) Up to 2304 per day (96 sequences

More information

7/6/2015. Cancer Related Deaths: United States. Management of NSCLC TODAY. Emerging mutations as predictive biomarkers in lung cancer: Overview

7/6/2015. Cancer Related Deaths: United States. Management of NSCLC TODAY. Emerging mutations as predictive biomarkers in lung cancer: Overview Emerging mutations as predictive biomarkers in lung cancer: Overview Kirtee Raparia, MD Assistant Professor of Pathology Cancer Related Deaths: United States Men Lung and bronchus 28% Prostate 10% Colon

More information

Genomic Instability. Kent Nastiuk, PhD Dept. Cancer Genetics Roswell Park Cancer Institute. RPN-530 Oncology for Scientist-I October 18, 2016

Genomic Instability. Kent Nastiuk, PhD Dept. Cancer Genetics Roswell Park Cancer Institute. RPN-530 Oncology for Scientist-I October 18, 2016 Genomic Instability Kent Nastiuk, PhD Dept. Cancer Genetics Roswell Park Cancer Institute RPN-530 Oncology for Scientist-I October 18, 2016 Previous lecturers supplying slides/notes/inspiration Daniel

More information

Genetic Analysis of Anxiety Related Behaviors by Gene Chip and In situ Hybridization of the Hippocampus and Amygdala of C57BL/6J and AJ Mice Brains

Genetic Analysis of Anxiety Related Behaviors by Gene Chip and In situ Hybridization of the Hippocampus and Amygdala of C57BL/6J and AJ Mice Brains Genetic Analysis of Anxiety Related Behaviors by Gene Chip and In situ Hybridization of the Hippocampus and Amygdala of C57BL/6J and AJ Mice Brains INTRODUCTION To study the relationship between an animal's

More information

Dr Catherine Woolnough, Hospital Scientist, Chemical Pathology, Royal Prince Alfred Hospital. NSW Health Pathology University of Sydney

Dr Catherine Woolnough, Hospital Scientist, Chemical Pathology, Royal Prince Alfred Hospital. NSW Health Pathology University of Sydney Dr Catherine Woolnough, Hospital Scientist, Chemical Pathology, Royal Prince Alfred Hospital NSW Health Pathology University of Sydney Thyroid Cancer TC incidence rates in NSW Several subtypes - Papillary

More information

Diagnostics for the early detection and prevention of colon cancer

Diagnostics for the early detection and prevention of colon cancer Diagnostics for the early detection and prevention of colon cancer Cologuard Test Crosswalk Proposal July 14 th, 2014 Colorectal cancer: the second-leading U.S. cancer killer Annual U.S. cancer mortality

More information

micrornas (mirna) and Biomarkers

micrornas (mirna) and Biomarkers micrornas (mirna) and Biomarkers Small RNAs Make Big Splash mirnas & Genome Function Biomarkers in Cancer Future Prospects Javed Khan M.D. National Cancer Institute EORTC-NCI-ASCO November 2007 The Human

More information

PHD STUDENTSHIP PROJECT PROPOSAL

PHD STUDENTSHIP PROJECT PROPOSAL The Institute of Cancer Research PHD STUDENTSHIP PROJECT PROPOSAL PROJECT DETAILS Project Title: Short Project Title: SUPERVISORY TEAM Primary Supervisor(s): Understanding therapeutic responses in BRCA

More information

Refining Prognosis of Early Stage Lung Cancer by Molecular Features (Part 2): Early Steps in Molecularly Defined Prognosis

Refining Prognosis of Early Stage Lung Cancer by Molecular Features (Part 2): Early Steps in Molecularly Defined Prognosis 5/17/13 Refining Prognosis of Early Stage Lung Cancer by Molecular Features (Part 2): Early Steps in Molecularly Defined Prognosis Johannes Kratz, MD Post-doctoral Fellow, Thoracic Oncology Laboratory

More information

Tumor Progression from an Evolutionary and Ecological Perspective

Tumor Progression from an Evolutionary and Ecological Perspective Tumor Progression from an Evolutionary and Ecological Perspective José Costa, M.D. Department of Pathology, Yale School of Medicine I. Liminary Remarks II. III. IV. The Standard Models of Tumor Progression

More information

Session 4 Rebecca Poulos

Session 4 Rebecca Poulos The Cancer Genome Atlas (TCGA) & International Cancer Genome Consortium (ICGC) Session 4 Rebecca Poulos Prince of Wales Clinical School Introductory bioinformatics for human genomics workshop, UNSW 28

More information

Development of important genes during breast carcinogenesis

Development of important genes during breast carcinogenesis Nagoya Med. J., 107 Development of important genes during breast carcinogenesis AYA NAIKI-ITO Department of experimental pathology and tumor biology Nagoya City University Graduate School of Medical Sciences

More information

Dr C K Kwan. Associate Consultant, Queen Elizabeth Hospital, HKSAR Honorary member, Targeted Therapy Team, ICR, UK

Dr C K Kwan. Associate Consultant, Queen Elizabeth Hospital, HKSAR Honorary member, Targeted Therapy Team, ICR, UK HA Convention 2013 Dr C K Kwan MBChB, FRCR, FHKCR, FHKAM, MPM, CPI, MAppMgt(Hlth) Associate Consultant, Queen Elizabeth Hospital, HKSAR Honorary member, Targeted Therapy Team, ICR, UK To personalize cancer

More information

Identification of Microbes Lecture: 12

Identification of Microbes Lecture: 12 Diagnostic Microbiology Identification of Microbes Lecture: 12 Electron Microscopy 106 virus particles per ml required for visualization, 50,000-60,000 magnification normally used. Viruses may be detected

More information

PD-L1 Analyte Control DR

PD-L1 Analyte Control DR Quality in Control PD-L1 Analyte Control DR PD-L1_PI_v2 Product Codes: HCL019, HCL020 and HCL021 Contents PD-L1 Analyte Control DR 2 What is PD-L1? 3 The Role of PD-L1 in Cancer 3 PD-L1 Assessment 4 PD-L1

More information

Biomarkers for Tuberculosis. Robert S. Wallis, MD, FIDSA Senior Director, Pfizer

Biomarkers for Tuberculosis. Robert S. Wallis, MD, FIDSA Senior Director, Pfizer Biomarkers for Tuberculosis Robert S. Wallis, MD, FIDSA Senior Director, Pfizer TB Global Burden total cases WHO 2009 TB Global Burden case rates WHO 2009 HIV prevalence in TB cases WHO 2009 TB Trends

More information

VIRUSES. Biology Applications Control. David R. Harper. Garland Science Taylor & Francis Group NEW YORK AND LONDON

VIRUSES. Biology Applications Control. David R. Harper. Garland Science Taylor & Francis Group NEW YORK AND LONDON VIRUSES Biology Applications Control David R. Harper GS Garland Science Taylor & Francis Group NEW YORK AND LONDON vii Chapter 1 Virus Structure and 2.2 VIRUS MORPHOLOGY 26 Infection 1 2.3 VIRAL CLASSIFICATION

More information

Table of Contents (continued)

Table of Contents (continued) Emerging Molecular and Immunohematology Blood Typing, Grouping And Infectious Disease NAT Screening Assays And Companies Developing New Technologies and Products Table of Contents 1. Blood Typing and Grouping

More information

An Evaluation of Qualitative HIV-2 RNA Referral Testing

An Evaluation of Qualitative HIV-2 RNA Referral Testing An Evaluation of Qualitative HIV-2 RNA Referral Testing Linda M. Styer, Anne Gaynor, Laura Wesolowski, Steve Ethridge and Monica M. Parker Wadsworth Center, NYSDOH; APHL; Division of HIV/AIDS Prevention,

More information

RT-qPCR analysis of laser capture micro-dissected material from CD31 stained FFPE tissue sections

RT-qPCR analysis of laser capture micro-dissected material from CD31 stained FFPE tissue sections RT-qPCR analysis of laser capture micro-dissected material from CD31 stained FFPE tissue sections Julian Schuster, Beatrix Bahle, Andrea Herold, Sabine Lohmann Roche Innovation Center Penzberg, Germany

More information

CS 6824: Tissue-Based Map of the Human Proteome

CS 6824: Tissue-Based Map of the Human Proteome CS 6824: Tissue-Based Map of the Human Proteome T. M. Murali November 17, 2016 Human Protein Atlas Measure protein and gene expression using tissue microarrays and deep sequencing, respectively. Alternative

More information

Origin of oncogenes? Oncogenes and Proto-oncogenes. Jekyll and Hyde. Oncogene hypothesis. Retroviral oncogenes and cell proto-oncogenes

Origin of oncogenes? Oncogenes and Proto-oncogenes. Jekyll and Hyde. Oncogene hypothesis. Retroviral oncogenes and cell proto-oncogenes Oncogenes and Proto-oncogenes Jekyll and Hyde A double edged sword Origin of oncogenes? Oncogene hypothesis Retroviral oncogenes and cell proto-oncogenes (v-onc) (c-onc) The role of c-onc in cancer How

More information

Biopsia Líquida: Oncología en Tiempo Real. Federico Rojo Fundación Jiménez Díaz

Biopsia Líquida: Oncología en Tiempo Real. Federico Rojo Fundación Jiménez Díaz Biopsia Líquida: Oncología en Tiempo Real Federico Rojo Fundación Jiménez Díaz Liquid Biopsy in Cancer Liquid Biopsy in Cancer Publication Date: April 5, 2016 Blood Tests replace Surgical Biopsies to create

More information

Starting with MICROBIOLOGY

Starting with MICROBIOLOGY Starting with MICROBIOLOGY Micro means very small and biology is the study of living things. Microbes are the oldest form of life on Earth. They've been here for 3.8 billion years! Microbes live everywhere.

More information

Chapter 18. Viral Genetics. AP Biology

Chapter 18. Viral Genetics. AP Biology Chapter 18. Viral Genetics 2003-2004 1 A sense of size Comparing eukaryote bacterium virus 2 What is a virus? Is it alive? DNA or RNA enclosed in a protein coat Viruses are not cells Extremely tiny electron

More information

Complete Transcriptome Analysis of Latently Infected CD4 + T Cells

Complete Transcriptome Analysis of Latently Infected CD4 + T Cells Towards an HIV Cure Pre-Conference Symposium 20 & 21 July 2012 Complete Transcriptome Analysis of Latently Infected CD4 + T Cells Fabio Romerio Institute of Human Virology University of Maryland School

More information

Molecular biology of colorectal cancer

Molecular biology of colorectal cancer Molecular biology of colorectal cancer Phil Quirke Yorkshire Cancer Research Centenary Professor of Pathology University of Leeds, UK Rapid pace of molecular change Sequencing changes 2012 1,000 genomes

More information

CUP: Treatment by molecular profiling

CUP: Treatment by molecular profiling CUP: Treatment by molecular profiling George Pentheroudakis Professor of Oncology Medical School, University of Ioannina Greece Chair, ESMO Guidelines September 2018 Enterprise Interest No disclosures.

More information

ROLE OF TGF-BETA SIGNALING IN PIK3CA-

ROLE OF TGF-BETA SIGNALING IN PIK3CA- ROLE OF TGF-BETA SIGNALING IN - DRIVEN HEAD AND NECK CANCER INVASION AND METASTASIS 1,2 Sophia Bornstein, 3 Jingping Shen, 3 Jacob Minor, 3 Frank Hall, 3 Fang Zhang, 4 Sherif Said, 4 Xiao-Jing Wang, 1

More information

Index. Index 439. Aequorin, 84, 94 Affinity precipitation, 372, AP-1, 100 Asthma, 170, 305

Index. Index 439. Aequorin, 84, 94 Affinity precipitation, 372, AP-1, 100 Asthma, 170, 305 Index 439 Index A Aequorin, 84, 94 Affinity precipitation, 372, 376 381 AP-1, 100 Asthma, 170, 305 B Bioassay, 185, comparison with ELISA, 318 GM-CSF bioassay, 351 IL-2 bioassay, 185 192, 300 IL-3 IL-6

More information

Basket and Umbrella Trial Designs in Oncology

Basket and Umbrella Trial Designs in Oncology Basket and Umbrella Trial Designs in Oncology Eric Polley Biomedical Statistics and Informatics Mayo Clinic Polley.Eric@mayo.edu Dose Selection for Cancer Treatment Drugs Stanford Medicine May 2017 1 /

More information

Screening for Complex Phenotypes

Screening for Complex Phenotypes Screening for Complex Phenotypes Michael Hemann hemann@mit.edu Screening for cancer phenotypes in mice How do we typically model cancer in mice? Tumor Suppressor KO Oncogene transgenesis Problems with

More information

microrna Presented for: Presented by: Date:

microrna Presented for: Presented by: Date: microrna Presented for: Presented by: Date: 2 micrornas Non protein coding, endogenous RNAs of 21-22nt length Evolutionarily conserved Regulate gene expression by binding complementary regions at 3 regions

More information

Malaria Rapid Diagnostic Tests: role and place in the diagnosis of malaria

Malaria Rapid Diagnostic Tests: role and place in the diagnosis of malaria Malaria Rapid Diagnostic Tests: role and place in the diagnosis of malaria 1 Plasmodium falciparum Malaria : an overview 2 Plasmodium vivax 3 Plasmodium ovale Most serious Jan Jacobs Institute of Tropical

More information

Abstract. Optimization strategy of Copy Number Variant calling using Multiplicom solutions APPLICATION NOTE. Introduction

Abstract. Optimization strategy of Copy Number Variant calling using Multiplicom solutions APPLICATION NOTE. Introduction Optimization strategy of Copy Number Variant calling using Multiplicom solutions Michael Vyverman, PhD; Laura Standaert, PhD and Wouter Bossuyt, PhD Abstract Copy number variations (CNVs) represent a significant

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Merritt WM, Lin YG, Han LY, et al. Dicer, Drosha, and outcomes

More information

Safety and Efficacy of Inotersen in Patients with Hereditary Transthyretin Amyloidosis with Polyneuropathy (NEURO-TTR) Annabel K.

Safety and Efficacy of Inotersen in Patients with Hereditary Transthyretin Amyloidosis with Polyneuropathy (NEURO-TTR) Annabel K. Safety and Efficacy of Inotersen in Patients with Hereditary Transthyretin Amyloidosis with Polyneuropathy (NEURO-TTR) Annabel K. Wang, MD University of California, Irvine ANA 2017 October 17, 2017 San

More information

April 5, :45 AM 1:45 PM MARRIOTT MARQUIS HOTEL & MARINA, MIRAMAR VIGNETTE 1 VIGNETTE 2 VIGNETTE 3* VIGNETTE 4* VIGNETTE 5*

April 5, :45 AM 1:45 PM MARRIOTT MARQUIS HOTEL & MARINA, MIRAMAR VIGNETTE 1 VIGNETTE 2 VIGNETTE 3* VIGNETTE 4* VIGNETTE 5* April 5, 2016 11:45 AM 1:45 PM MARRIOTT MARQUIS HOTEL & MARINA, MIRAMAR CHAIR: DANNY A. MILNER, JR., BRIGHAM & WOMEN S HOSPITAL, BOSTON, MA VIGNETTE 1 VIGNETTE 2 VIGNETTE 3* VIGNETTE 4* VIGNETTE 5* *VIGNETTES

More information

Molecular imprinting of radiation induced cancer S Chevillard

Molecular imprinting of radiation induced cancer S Chevillard Molecular imprinting of radiation induced cancer S Chevillard The risk of cancer is clearly demonstrated at high doses and high dose rates The risk at low doses remains highly controversial The overall

More information